Patanjali Ayurved controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile10 entries
2024
Supreme Court misleading-advertising proceedings
The Supreme Court restricted Patanjali advertisements and required apologies in proceedings concerning unsupported health claims. The Uttarakhand licensing authority revoked 14 product licences during the regulatory response.
2023
Allegation concerning animal-derived material in a vegetarian product
A Delhi law firm issued a notice alleging that a dental-care product contained cuttlefish bone despite being presented as vegetarian. The allegation was reported as a legal dispute rather than an established finding.
2022
Dispute over statements attacking allopathic medicine
The Indian Medical Association pursued legal action after Ramdev made statements criticizing evidence-based and allopathic medicine while promoting Patanjali products.
2021
Disputed WHO and government approval claims
Patanjali-associated statements implied WHO certification and government approval of Coronil’s efficacy. The WHO rejected the certification implication, and the company clarified that its authorization did not constitute proof of treatment effectiveness.
2020
Coronil COVID-19 treatment claims
Patanjali’s launch claims were challenged because available evidence did not establish Coronil as a safe or effective cure for COVID-19. Authorities, courts and multiple jurisdictions took steps to limit or clarify the product’s promotion.
2020
Patanjali ordered to pay ₹75.08 crore over GST benefits
Fine or penalty
India's National Anti-Profiteering Authority ordered Patanjali Ayurveda Ltd to pay ₹75.08 crore, plus 18% GST, for not passing GST rate-reduction benefits on to consumers. The authority said the company increased washing-powder prices and directed it to deposit the amount in consumer welfare funds within three months.
India’s National Anti-Profiteering Authority ordered Patanjali Ayurveda Ltd to pay ₹75.08 crore, plus 18% GST, for not passing GST rate-reduction benefits on to consumers. The authority said the company increased washing-powder prices and directed it to deposit the amount in consumer welfare funds within three months.
Source excerpt
The National Anti-Profiteering Authority (NAA) has ordered Patanjali Ayurveda Ltd to pay up Rs 75.08 crore for not passing on benefits of goods and services tax (GST) rate reduction on to consumers, adding that the company instead increased prices of its washing powder.
The authority has directed the company to deposit the amount, along with 18% GST, to consumer welfare funds of Centre and the states within three months, according to an order passed on March 12.
2018
Environmental allegations near Haridwar facility
Residents alleged that runoff from a Patanjali-linked facility polluted local water channels and harmed animals. The environmental authority ordered clean-up measures; the company denied breaching established protocols.
2017
Chyawanprash advertising dispute
The Delhi High Court ordered Patanjali to stop airing an advertisement for chyawanprash that was found to disparage a competitor.
2015
Product licensing and quality disputes
Food-safety authorities questioned approvals for Patanjali instant noodles, while reported testing also raised concerns about the quality of some products including mustard oil and amla juice.
2015
Divya Putrajeevak Seed controversy
Critics objected to the product’s name and alleged that some sellers presented it as promising the birth of a boy. Government bodies examined whether the product conflicted with Indian laws concerning sex selection and reproductive claims.